| Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK M Voysey, SAC Clemens, SA Madhi, LY Weckx, PM Folegatti, PK Aley, ... The Lancet 397 (10269), 99-111, 2021 | 5274 | 2021 |
| Single Dose Administration, And The Influence Of The Timing Of The Booster Dose On Immunogenicity and Efficacy Of ChAdOx1 nCoV-19 (AZD1222) Vaccine M Voysey, SA Costa Clemens, SA Madhi, LY Weckx, PM Folegatti, ... The Lancet, 2021 | 1324 | 2021 |
| Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 lineages circulating in Brazil SAC Clemens, PM Folegatti, KRW Emary, LY Weckx, J Ratcliff, S Bibi, ... Nature Communications 12 (1), 5861, 2021 | 46 | 2021 |
| O impacto da hepatite delta T Figueiredo Mendes, JP Simonetti, JCF Fonseca, SRR Simonetti, ... Moderna Hepatologia 9, 16-22, 1984 | 9 | 1984 |
| Transmissão sexual do vírus da hepatite B TF Mendes, PRS Cruz, AM Pittella, PPF Mexas, N Podkamen, B Herbet Moderna Hepatologia 3, 1-6, 1982 | 7 | 1982 |
| Análise da soropositividade do anti-HBs em profissionais de saúde AN Nazar, AP Bastos, AM Pittella, HJ Matos Cad. saúde colet.,(Rio J.) 16 (3), 2008 | 6 | 2008 |
| Recentes Avanços em Hepatites TF MENDES, AM PITTELLA Recentes Avanços em Hepatites. São Paulo, Fundo Editorial BYK, 1994 | 6 | 1994 |
| O portador crônico do VHB: implicaçöes clínicas e epidemiológicas CB Mendes, AM Pittella Arq Bras Med 63 (2), 74-5, 1989 | 5 | 1989 |
| Resistance mutations A30K and Y93N associated with treatment failure with sofosbuvir and daclatasvir for hepatitis C virus infection non-responder patients VD Costa, P Pellegrini, V Rotman, AM Pittella, EP Nunes, BV Lago, ... Viruses 11 (11), 1004, 2019 | 3 | 2019 |
| Hepatite B no Rio de Janeiro TF Mendes, AM Pittella, BA Herbert Moderna Hepatologia 14, 14-18, 1989 | 3 | 1989 |
| Marcadores virais no diagnóstico da hepatite T Mendes, AM Pittella, JP Simonetti Marcadores virais no diagnóstico da Hepatite, 31-31, 1986 | 3 | 1986 |
| How Cardiac Fibrosis Assessed via T1 Mapping Is Associated with Liver Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease FVO Terzi, GC Camargo, DB Parente, AM Pittella, G Silva-Junior, ... Journal of Clinical Medicine 12 (23), 7381, 2023 | | 2023 |
| New insights on the mechanisms of myocardial injury in hypertensive patients with COVID-19 R Moll-Bernardes, JR Ferreira, EB Schaustz, AS Sousa, JD Mattos, ... Journal of Clinical Immunology 43 (7), 1496-1505, 2023 | | 2023 |
| Insights on Treating HCV-Related B Cell Non-Hodgkin Lymphoma A Pittella, E Atta, L Gomes, CC Silva, AA Pimenta Clinical Lymphoma, Myeloma and Leukemia 16, S112-S113, 2016 | | 2016 |
| Síndrome Hepatorrenal AM PITTELLA, E MACCARIELLO Tratado de Clínica Médica (2ª ed.) 1, 1280-1285, 2009 | | 2009 |
| Drenagem percutânea de abscesso hepático piogênico multiloculado: relato de caso FA Silva, AM Pittela, GB Villa, HS Martin, R Mourilhe GED gastroenterol. endosc. dig, 17-22, 2008 | | 2008 |
| Síndrome Hepatorrenal AM PITTELLA, AN NAZAR Tratado de Clínica Médica (1ª ed.) 1, 1360-1365, 2006 | | 2006 |
| Critic analysis of Law# 863 H Sette, H Cheinquer, EPA Lopes, R Parana, MG Pessoa, AM Pittella, ... REVISTA BRASILEIRA DE MEDICINA 60 (5), 274-276, 2003 | | 2003 |
| Análise crítica da Portaria numero 863 (DOU, 4 de novembro de 2002) H Sette Junior, H Cheinquer, E Lopes, R Paraná, MG Pessoa, AM Pittella, ... RBM rev. bras. med, 274-276, 2003 | | 2003 |
| Hepatite C: complicações extra-hepáticas AM Pittella, ALS Souza, A Nazar Tratado de hepatites virais, 247-251, 2002 | | 2002 |
Isabel Kinney Ferreira de Miranda San...Faculdade de Medicina de Ribeirão PretoVerified email at fmrp.usp.br
